Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors.
Su, D.S., Qu, J., Schulz, M., Blackledge, C.W., Yu, H., Zeng, J., Burgess, J., Reif, A., Stern, M., Nagarajan, R., Pappalardi, M.B., Wong, K., Graves, A.P., Bonnette, W., Wang, L., Elkins, P., Knapp-Reed, B., Carson, J.D., McHugh, C., Mohammad, H., Kruger, R., Luengo, J., Heerding, D.A., Creasy, C.L.(2020) ACS Med Chem Lett 11: 133-140
- PubMed: 32071679 
- DOI: 10.1021/acsmedchemlett.9b00493
- Primary Citation of Related Structures:  
6P6G, 6P6K, 6P7Z, 6PAF - PubMed Abstract: 
We report herein the discovery of isoxazole amides as potent and selective SET and MYND Domain-Containing Protein 3 (SMYD3) inhibitors. Elucidation of the structure-activity relationship of the high-throughput screening (HTS) lead compound 1 provided potent and selective SMYD3 inhibitors ...